FNY Managed Accounts’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-16,000
Closed -$1.22M 884
2017
Q3
$1.22M Buy
+16,000
New +$1.21M 1.59% 19
2017
Q2
Sell
-1,500
Closed -$97K 719
2017
Q1
$97K Buy
+1,500
New +$88.3K 0.3% 94
2016
Q2
Sell
-16,221
Closed -$694K 456
2016
Q1
$694K Buy
+16,221
New +$685K 1.21% 19

Other funds holding PRAH

FNY Managed Accounts's PRAH Position: Q4 2017 in Review

FNY Managed Accounts sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 16,000 shares — an estimated $1.22M sold.

FNY Managed Accounts first reported a position in PRAH in Q1 2016 and held it in 3 quarters. The position peaked at $1.22M in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • FNY Managed Accounts reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 16,000 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $1.22M.
  • FNY Managed Accounts first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 3 quarters.
  • FNY Managed Accounts's PRA Health Sciences, Inc. position peaked at $1.22M in Q3 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on FNY Managed Accounts's 13F filing for Q4 2017, filed 23 Jan 2018.